Cargando…

Myb drives B-cell neoplasms and myeloid malignancies in vivo

Detalles Bibliográficos
Autores principales:	Pieters, Tim, Almeida, André, T'Sas, Sara, Lemeire, Kelly, Hochepied, Tino, Berx, Geert, Kentsis, Alex, Goossens, Steven, Van Vlierberghe, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131915/ https://www.ncbi.nlm.nih.gov/pubmed/35020834 http://dx.doi.org/10.1182/bloodadvances.2021005955

Ejemplares similares

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies
por: Pieters, Tim, et al.
Publicado: (2019)

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice
por: Pieters, Tim, et al.
Publicado: (2021)

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms
por: Goossens, Steven, et al.
Publicado: (2019)

A new mouse model to study the role of ectopic Nanos3 expression in cancer
por: Andries, Vanessa, et al.
Publicado: (2019)

Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
por: Goossens, Steven, et al.
Publicado: (2021)

p120 Catenin-Mediated Stabilization of E-Cadherin Is Essential for Primitive Endoderm Specification
por: Pieters, Tim, et al.
Publicado: (2016)

S239: SOX11 DRIVES B1A LINEAGE COMMITMENT AND B1A/MCL-LIKE LYMPHOMA FORMATION IN MICE
por: Pieters, Tim, et al.
Publicado: (2023)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Peptidomimetic blockade of MYB in acute myeloid leukemia
por: Ramaswamy, Kavitha, et al.
Publicado: (2018)

Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms
por: Kleinberger, Irene, et al.
Publicado: (2022)

PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms
por: Lee, Ji Hyun, et al.
Publicado: (2019)

Snail in the frame of malignant tumor recurrence
por: De Craene, Bram, et al.
Publicado: (2006)

Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia
por: Takao, Sumiko, et al.
Publicado: (2021)

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression
por: Berx, Geert, et al.
Publicado: (2001)

Efficient and User-Friendly Pluripotin-based Derivation of Mouse Embryonic Stem Cells
por: Pieters, Tim, et al.
Publicado: (2011)

MYB sommeliers: MYB24 drives UV response on the light side of variegated grape
por: Bascom, Carlisle
Publicado: (2023)

Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression
por: Foubert, Ellen, et al.
Publicado: (2010)

Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation?
por: Mitchell, Jenee, et al.
Publicado: (2021)

Controlling Pre-leukemic Thymocyte Self-Renewal
por: Goossens, Steven, et al.
Publicado: (2014)

Overcoming Steroid Resistance in T Cell Acute Lymphoblastic Leukemia
por: Goossens, Steven, et al.
Publicado: (2016)

Regulation of MYB by distal enhancer elements in human myeloid leukemia
por: Li, Mengjia, et al.
Publicado: (2021)

Human decellularized dermal matrix seeded with adipose-derived stem cells enhances wound healing in a murine model: Experimental study
por: Doornaert, M., et al.
Publicado: (2019)

Overexpression of MYB drives proliferation of CYLD‐defective cylindroma cells
por: Rajan, Neil, et al.
Publicado: (2016)

Co-occurrence of myeloid neoplasm and plasma cell neoplasm
por: Jum’ah, Husam, et al.
Publicado: (2022)

Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia
por: Ramaswamy, Kavitha, et al.
Publicado: (2015)

Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice
por: Renard, Marjolijn, et al.
Publicado: (2018)

Clinical features and prognosis of duplex primary malignant neoplasms involving chronic myeloid leukemia
por: Liu, Chunshui, et al.
Publicado: (2020)

Extracellular Vesicles in Myeloid Neoplasms
por: Karantanou, Christina, et al.
Publicado: (2022)

MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia
por: Frech, Miriam, et al.
Publicado: (2018)

Identification of a c-MYB-directed therapeutic for acute myeloid leukemia
por: Clesham, Katherine, et al.
Publicado: (2022)

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
por: Gianelli, Umberto, et al.
Publicado: (2022)

MYB-QKI drives childhood brain tumors via tripartite mechanism
por: Jain, Payal, et al.
Publicado: (2016)

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations
por: Volpe, Giacomo, et al.
Publicado: (2019)

Myb expression is critical for myeloid leukemia development induced by Setbp1 activation
por: Nguyen, Nhu, et al.
Publicado: (2016)

Myeloid Neoplasms in the Guise of Nutritional Deficiency
por: Parthasarathy, Veda
Publicado: (2012)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Bone marrow niches in myeloid neoplasms
por: Kitagawa, Masanobu, et al.
Publicado: (2019)

Editorial: Immunologic Mechanisms of Myeloid Neoplasms
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Analysis of flavonol regulator evolution in the Brassicaceae reveals MYB12, MYB111 and MYB21 duplications and MYB11 and MYB24 gene loss
por: Schilbert, Hanna M., et al.
Publicado: (2022)

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
por: Tapper, William, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cpq44919njhreh9ejj5ccg7v0v